[ Ссылка ]
We reviewed special HTA and reimbursement considerations introduced for assessment of orphan drugs in Europe and present implications for manufacturers. [ Ссылка ]
ICPE Barcelona 2018
![](https://s2.save4k.ru/pic/_vqi_FBVdaY/maxresdefault.jpg)
[ Ссылка ]
We reviewed special HTA and reimbursement considerations introduced for assessment of orphan drugs in Europe and present implications for manufacturers. [ Ссылка ]
ICPE Barcelona 2018